Goldman Sachs
FLAC

Goldman Sachs’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Goldman Sachs’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-497,489
Closed -$4.96M – 6565
2022
Q3 		$4.96M Sell
497,489
-3,798
-0.8% -$37.7K ﹤0.01% 3142
2022
Q2 		$4.95M Sell
501,287
-20,061
-4% -$198K ﹤0.01% 3142
2022
Q1 		$5.13M Buy
+521,348
New +$5.11M ﹤0.01% 3330

Goldman Sachs's FLAC Position: Q4 2022 in Review

Goldman Sachs sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 497,489 shares — an estimated $4.96M sold.

Goldman Sachs first reported a position in FLAC in Q1 2022 and held it in 3 quarters. The position peaked at $5.13M in Q1 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

  • Goldman Sachs reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 497,489 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $4.96M.
  • Goldman Sachs first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2022 and held it in 3 quarters.
  • Goldman Sachs's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $5.13M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.